ClinicalTrials.gg
CompletedNCT06974214FAM-ICUUpdated Oct 29, 2026

Patient- and Family-centred Care in the Adult Intensive Care Unit: a Feasibility Study

An interventional study of FAM-ICU in Delirium, Anxiety and Post Intensive Care Unit Syndrome, sponsored by Herlev Hospital. Completed at 1 site in Denmark. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Herlev Hospital · Not applicable, Interventional, and Prevention

How we know

Updated Oct 29, 2026Now CompletedFirst site in Denmark+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 26 studies in Delirium with a site in Denmark — 1 open to participants now, 3 under way, 1 of them phase 3. Delirium · Denmark.

Enrollment
10th of 12
60 · median 175
Started
2025
with 1 other
No phase
8 of 26
1 open now
Registered
26th of 26
by date

Among the 26 studies in Delirium with a site in Denmark, this one is the 10th largest by enrollment of the 12 interventional ones that give a count, is one of 2 that started in 2025, is one of 8 with no phase, and was the 26th registered.

Delirium

935 studies on the registry are indexed under Delirium; 188 are open to participants now.

Browse Delirium studies →

Open to participants now

1 of the 26 studies in Delirium with a site in Denmark is open now. Recruiting first, the newest first:

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Delirium with a site in Denmark, or all of them as a file.
02

Study summary

Background: In the intensive care unit (ICU), delirium in patients and long-term mental health challenges in both patients and their family members are highly prevalent. To address these issues, patient- and family-centered care has been recommended to alleviate the burdens associated with critical illness and ICU admission. We have developed the patient- and FAMily-centered care in the adult ICU intervention (FAM-ICU intervention). This multi-component intervention comprises several concrete and manageable components and operationalizing patient- and family-centered care principles in clinical practice. In this protocol, we describe a study aiming to evaluate the feasibility and acceptability of the FAM-ICU intervention in the adult ICU setting, including the feasibility of collecting relevant patient- and family-member outcome data.

Referenc: Bohart et al. 2024. Acta Anaesthesiol Scand

. 2025 Jan;69(1):e14539. doi: 10.1111/aas.14539. Epub 2024 Oct 24. Method: We will conduct a pre-/post two-group study design. We plan to recruit 30 adult ICU patients and their close family members at Herlev University Hospital in Denmark. The pre-group (n = 15) will receive usual care and the post-group (n = 15) will receive the FAM-ICU intervention. The FAM-ICU intervention involves interdisciplinary training of the ICU team and a systematic approach to information sharing and consultations with the patients and their family. Feasibility outcomes will include recruitment and retention rates, intervention fidelity, and the feasibility of participant outcome data collection. Acceptability will be assessed through questionnaires and interviews with clinicians, patients, and family members. Data collection is scheduled to begin in January 2025.

Discussion: This study will assess the feasibility and acceptability when implementing the FAM-ICU intervention and the feasibility of conducting a main trial to investigate its effectiveness on delirium in patients and the mental health of patients and family members. The data from the feasibility study will be used to guide sample size calculations, trial design, and final data collection methods for a subsequent stepped-wedge randomized controlled trial.

03

Conditions studied

  • Delirium
  • Anxiety
  • Post Intensive Care Unit Syndrome
  • Post Intensive Care Unit Syndrome Family
  • Depression
  • Posttraumatic Stress Disorder (PTSD)
  • Mortality
  • Length of ICU Stay
  • Pain
  • Satisfaction Survey

Keywords

  • Patient- and family-centerede care
  • Feasibility
  • ICU
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Patients are eligible if they are:

  • ≥18 years of age.
  • Expected to require ICU admission for at least 48 hours in a mixed surgical and medical ICU for adult critically ill patients.

Family members are eligible if they are:

  • ≥18 years of age.
  • a close family member to a patient-enrolled in the FAM-ICU. A family-member can be blood-related or not. It may be a spouse, relative, partner, or friend as determined by the patient as a close family member.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • No intervention
    usual care

    The group receives usual care.

  • Experimental
    FAM-ICU intervention

    The group receives the FAM-ICU intervention

    Other: FAM-ICU

Interventions

  • OtherFAM-ICU

    This multi-component intervention comprises several concrete and manageable components and operationalizing patient- and family-centered care principles in clinical practice.

06

What researchers measure

Primary outcomes

  1. Feasibility, recruitment rate

    Number of approached participants who consent to participate.

    Time frame: during ICU admission.

  2. Feasibility, Retention rate

    The number of non-responders to the self-reported questionnaires at 6 months.

    Time frame: 1 month post ICU admission

  3. Feasibility, Fidelity

    The frequency and resource use of intervention delivery. Free text describing experienced barriers and facilitators for completing/not completing an intervention component.

    Time frame: during ICU admission.

  4. Acceptability, Adherence

    Willingness to follow the intervention (Including barriers and facilitators).

    Time frame: during ICU admission.

  5. Acceptability, Appropriateness

    Perception of how suitable the intervention is for the target population,

    Time frame: during ICU admission.

  6. Acceptability, Convenience

    The intervention intrusiveness (how easy is it to apply)

    Time frame: during ICU admission.

  7. Acceptability, effectiveness

    Perception of whether the intervention helps manage the problem.

    Time frame: during ICU admission.

Secondary outcomes

  1. Free of delirium

    Number of delirium free days assessed by Confusion assessment method ICU (CAM-ICU)

    Time frame: during ICU admission.

  2. Anxiety, patients

    Symptoms of anxiety, using Hospital Anxiety and Depression Scale

    Time frame: 1 month post ICU admission

  3. Depression, patients

    Symptoms of depression using Hospital Anxiety and Depression Scale.

    Time frame: 1 month post ICU admission

  4. PTSD, patients

    Symptoms of PTSD using Harvard Trauma Questionnaire part 4 (HTQ-lV).

    Time frame: 1 month post ICU admission

  5. Health-related quality of life, patients

    Assessed using EQ-5D

    Time frame: 1 month post ICU admission

  6. Free of life support

    Days without mechanical ventilation, receiving vasopressors and undergoing dialysis.

    Time frame: during ICU admission.

  7. Survival

    Days alive.

    Time frame: 1 month post ICU admission

  8. Employment status, patient

    Employment as full-time, part-time, unemployed, self-employed, (paid/unpaid) on leave, student, or retired.

    Time frame: 1 month post ICU admission

  9. Cognitive function

    Assessed using Mini Montreal Cognitive Assessment (Mini MoCA).

    Time frame: 1 month post ICU admission

  10. Out of hospital

    Number of days out of hospital

    Time frame: 1 month post ICU admission

  11. Anxiety, family

    Symptoms of anxiety using HADS

    Time frame: 1 month post ICU admission

  12. Depression, family

    Symptoms of depression using HADS

    Time frame: 1 post ICU admission

  13. PTSD, family

    Symptoms of PTSD using HTQ

    Time frame: 1 month post ICU admission

  14. Satisfaction, family

    Survey for family-members regarding satisfaction.

    Time frame: At ICU discharge.

  15. Employment status, family

    Employment as full-time, part-time, unemployed, self-employed, (paid/unpaid) on leave, student, or retired.

    Time frame: 1 month post ICU admission

  16. Anxiety, patients

    Symptoms of anxiety, using Hospital Anxiety and Depression Scale

    Time frame: 6 months post ICU

  17. Depression, patients

    Symptoms of depression using Hospital Anxiety and Depression Scale.

    Time frame: 6 months post ICU

  18. PTSD, patients

    Symptoms of PTSD using Harvard Trauma Questionnaire part 4 (HTQ-lV).

    Time frame: 6 months post ICU

  19. Health-related quality of life, patients

    Assessed using EQ-5D

    Time frame: 6 months post ICU

  20. Survival

    Days alive.

    Time frame: 6 months post ICU

  21. Employment status, patient

    Employment as full-time, part-time, unemployed, self-employed, (paid/unpaid) on leave, student, or retired.

    Time frame: 6 months post ICU

  22. Cognitive function

    Assessed using Mini Montreal Cognitive Assessment (Mini MoCA).

    Time frame: 6 months post ICU

  23. Anxiety, family

    Symptoms of anxiety using HADS

    Time frame: 6 months post ICU

  24. Depression, family

    Symptoms of depression using HADS

    Time frame: 6 months post ICU

  25. PTSD, family

    Symptoms of PTSD using HTQ

    Time frame: 6 months post ICU

  26. Employment status

    Employment as full-time, part-time, unemployed, self-employed, (paid/unpaid) on leave, student, or retired.

    Time frame: 6 months post ICU

  27. Employment status, family

    Employment as full-time, part-time, unemployed, self-employed, (paid/unpaid) on leave, student, or retired.

    Time frame: 6 months post ICU

  28. Out of hospital

    Number of days out of hospital

    Time frame: 6 months post ICU

07

Study locations

1 site
  • Herlev Hospital
    Herlev, 2730, Denmark
08

References and documents

Publications

  • Bohart S, Waldau T, Andreasen AS, Moller AM, Thomsen T. Patient- and family-centered care in adult ICU (FAM-ICU): A protocol for a feasibility study. Acta Anaesthesiol Scand. 2025 Jan;69(1):e14539. doi: 10.1111/aas.14539. Epub 2024 Oct 24. PubMed 39445615 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2025 to primary completion in May 2026, 6 months.

Of 219 non-industry interventional studies with no phase under Delirium, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's 6 months is below that.

Counting every sponsor, half of 222 studies reached it within 26 months; a quarter within 12 and three quarters within 45.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 29, 2026: start Aug 2025 → Nov 2025, primary completion Dec 2025 → May 2026 and completion Aug 2026 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 30, 2025
First posted
May 15, 2025
StartActual
Nov 1, 2025was Aug 2025
Primary completionActual
May 1, 2026was Dec 2025
CompletionActual
Oct 1, 2026was Aug 2026
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Oct 29, 2026
Sites
1 site added — first site in Denmark
Show site
  • Herlev Hospital · Herlev, Denmark
Oct 29, 2026
Start date
Aug 1, 2025→Nov 1, 2025 (actual)
Oct 29, 2026
Primary completion
Dec 31, 2025→May 1, 2026 (actual)
Oct 29, 2026
Study completion
Aug 1, 2026→Oct 1, 2026 (actual)
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    Not yet recruiting→Completed
    1 site added — first site in Denmark
    Show site
    • Herlev Hospital · Herlev, Denmark
    Start date Aug 1, 2025→Nov 1, 2025 (now actual)
    Primary completion Dec 31, 2025→May 1, 2026 (now actual)
    Study completion Aug 1, 2026→Oct 1, 2026 (now actual)
    + 2 other changes: index terms and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06974214
Lead sponsor
Herlev Hospital
Responsible party
Søs Bohart (postdoc., Herlev Hospital) — Principal investigator
First posted
May 15, 2025
Start date
Nov 1, 2025
Primary completion
May 1, 2026
Completion
Oct 1, 2026
Last update
Oct 29, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion